• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA clears Wenzel Spine’s primaLOK for expanded indications

FDA clears Wenzel Spine’s primaLOK for expanded indications

August 22, 2023 By Sean Whooley

Wenzel Spine primaLOK SP system
The primaLOK SP system. [Image from Wenzel Spine]
Wenzel Spine announced today that it received FDA clearance for its primaLOK SP system for spinal fusion procedures.

Austin, Texas-based Wenzel Spine designed primaLOK SP to provide surgeons with an effective and reliable solution for spinal stabilization. It’s now commercially available in the U.S.

The system combines cutting-edge engineering with a patient-focused design, Wenzel Spine says. Its design aims to provide a comprehensive solution for spinal fusion procedures, according to the company. New clinical indications with FDA clearance allow for the use of primaLOK SP at multiple levels in treating lumbar spinal stenosis.

“We are proud to receive FDA clearance to update the clinical indications for primaLOK SP,” Wenzel Spine CEO William E. Wilson said. “This achievement reflects our ongoing commitment to innovation and excellence in our spinal solutions. We believe this system will significantly contribute to improved patient outcomes through a less invasive approach.”

What comprises the Wenzel Spine primaLOK SP system?

Features of primaLOK SP include a unique locking mechanism that ensures secure stabilization. This reduces the risk of migration and providing stability during the critical fusion process. It also enables precision and versatility with a high degree of flexibility. The system accommodates various patient anatomies and offers surgeons the ability to tailor each procedure to individual needs.

Wenzel Spine said the minimally invasive approach minimizes tissue disruption. That potentially leads to reduced post-operative pain, shorter hospital stays and quicker patient recovery. Its enhanced radiographic visibility also allows surgeons to confidently assess implant placement and fusion progress.

Texas-based neurosurgeon Dr. Charles Gordon called the system a “significant advancement for spinal fusion procedures.” Gordon founded Texas Spine & Joint Hospital in Tyler, Texas.

“Its versatile locking mechanism and patient-centric design truly set it apart,” Gordon said. “These expanded clinical indications will allow me to further incorporate this system into my practice and provide my patients with a higher level of care.”

Filed Under: 510(k), Food & Drug Administration (FDA), Implants, Orthopedics, Regulatory/Compliance, Spine Tagged With: FDA, Wenzel Spine

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy